Amarante, Inês, et al. “Full Recovery over One Year of the Overlap Syndrome Scleromyositis to Maintenance Therapy With Mycophenolate Mofetil and Rituximab, Which Relapsed Within 8 Months of Discontinuation”. European Journal of Case Reports in Internal Medicine, vol. 12, no. 5, May 2025, https://doi.org/10.12890/2025_005154.